March 2015
Together we can Cure Duchenne!
Biotech’s Path to Discovery: BioMarin CEO

Jean-Jacques Bienaime, BioMarin Pharmaceutical CEO, discusses his company’s bull run and news drugs to treat rare diseases, including Duchenne muscular dystrophy, on CNBC.

Powered By Convio